Uniphar

Uniphar Intangible Assets

The Intangible Assets of Uniphar (UPR.IR) as of Oct 16, 2026 is 59.70 M EUR. In the previous year, Intangible Assets was 44.57 M EUR — a change of 33.95% (higher).

Intangible Assets

59.70 MEUR

YoY

33.95%

Last updated:

Intangible Assets of Uniphar is 2024 59.70 M EUR. Intangible Assets of Uniphar was 2023 44.57 M EUR. It decreases by 33.95% higher compared to the previous year.

The Uniphar Intangible Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Intangible Assets
Date
Intangible Assets
Jan 1, 2017
7.36 M EUR
Jan 1, 2018
6.76 M EUR
Jan 1, 2019
277.78 M EUR
Jan 1, 2020
374.50 M EUR
Jan 1, 2021
22.97 M EUR
Jan 1, 2022
24.46 M EUR
Jan 1, 2023
44.57 M EUR
Jan 1, 2024
59.70 M EUR
The Uniphar Intangible Assets history
YEARIntangible AssetsYoY
59.70 MEUR+33.95%
44.57 MEUR+82.20%
24.46 MEUR+6.49%
22.97 MEUR-93.87%
374.50 MEUR+34.82%
277.78 MEUR+4,008.50%
6.76 MEUR-8.19%
7.36 MEUR-3.68%
7.65 MEUR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Uniphar Stock analysis

What does Uniphar do? Uniphar PLC is an Irish company that was founded in 1994 and operates in the healthcare industry. The company is headquartered in Dublin and employs over 2,500 people worldwide. The history of Uniphar began as a pharmacy distribution company that supplied medications to retailers and healthcare facilities. Over the years, however, the company has expanded its business model and now offers a wide range of healthcare products and services. Uniphar's business model encompasses three main areas: Healthcare Services, Commercial & Clinical Supply Chain, and Product Access & Specialty Medicines. In the Healthcare Services area, Uniphar provides consulting services, training, and leadership coaching for healthcare facilities. The Commercial & Clinical Supply Chain division includes the storage, logistics, and distribution of medications, as well as the clinical care of patients. The Product Access & Specialty Medicines division focuses on access to medications with high medical demand and rare diseases. Uniphar also offers a wide range of healthcare products, including generics, branded medications, and medical devices. The company has partnerships with leading pharmaceutical companies such as Pfizer, Eli Lilly, and Merck. In recent years, Uniphar has also made several significant acquisitions to expand and diversify its business. In 2018, the company acquired UK-based pharmaceutical distributor Cahill May Roberts, and in 2019, the acquisition of Durbin, an international supplier of clinical supply products, was completed. Uniphar is committed to improving healthcare in Ireland and worldwide and offers a wide range of products and services to achieve this goal. The company has earned a reputation as a reliable partner for healthcare facilities and pharmaceutical companies and is on a steady growth trajectory. Uniphar is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Uniphar stock

Intangible Assets of Uniphar is 59.70 M EUR in 2024.

Intangible Assets of Uniphar changed from 44.57 M EUR to 59.70 M EUR, representing a 33.95% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Intangible Assets Uniphar since 2006 – with annual values, charts, and detailed analysis.

Intangible assets are non-physical assets such as patents, trademarks, copyrights, and software. They can be significant value drivers for technology and pharmaceutical companies.

Intangible Assets's EUR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Intangible Assets's Uniphar historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Uniphar

All Key Metrics — Uniphar